MEDA: Edluar Approved in Europe
Published: Jun 15, 2012
GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Edluar has received registration approval in Europe via the decentralized procedure with Sweden acting as Reference Member State. Edluar is used for treating sleep disorders and contains zolpidem, a well-documented active ingredient. National registration processes will now follow in each country. The first launches are expected early next year.